SCHEMBL9852029

SCHEMBL9852029

NC(=O)CC(N)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)O

nearest known ligand 0.67

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ACE P12821 2/20 0.67
ECE1 P42892 7/20 0.62
KDM4E B2RXH2 1/20 0.62
MEN1 O00255 1/20 0.62
LMNA P02545 1/20 0.62
MPO P05164 1/20 0.62
MAPT P10636 1/20 0.62
TSHR P16473 1/20 0.62
BLM P54132 1/20 0.62
PMP22 Q01453 1/20 0.62
KMT2A Q03164 1/20 0.62
HIF1A Q16665 1/20 0.62
ALOX15 P16050 1/20 0.61
LTA4H P09960 1/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9852039 1.00 ACE (0.67) ACEECE1KDM4EMEN1LMNA
SCHEMBL30195254 0.94 ACE (0.59) ACEECE1KDM4EMEN1LMNA
SCHEMBL30389278 0.93 ACE (0.58) ACEECE1KDM4EMEN1LMNA
SCHEMBL30123058 0.92 ACE (0.63) ACEECE1ALOX15
SCHEMBL14941216 0.92 ACE (0.68) ACEECE1KDM4EMEN1LMNA
SCHEMBL29603940 0.92 ACE (0.68) ACEECE1KDM4EMEN1LMNA
SCHEMBL7422711 0.92 ACE (0.68) ACEECE1KDM4EMEN1LMNA
SCHEMBL31606512 0.92 ECE1 (0.65) ACEECE1KDM4EMEN1LMNA
SCHEMBL30390486 0.92 ACE (0.63) ACEECE1
SCHEMBL30724706 0.91 ACE (0.62) ACEECE1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-121577769-A Urine metabolism marker composition for diagnosing kidney cancer and application thereof 哈尔滨脉图精准技术有限公司 2026-02-27 CN claimed
CN-103694314-B Preparation method of active peptide with snake venom source SHANGHAI INST PHARM INDUSTRY 2015-03-25 CN claimed
EP-0457314-A1 Nutrient compositions containing peptides CLINTEC NUTRITION COMPANY (US) 1991-11-21 EP claimed
EP-3604503-B1 ADDITIVE FOR UNDIFFERENTIATION MAINTAINING MEDIUM AJINOMOTO KK (JP) 2026-03-18 EP disclosed
CN-121577769-A Urine metabolism marker composition for diagnosing kidney cancer and application thereof 哈尔滨脉图精准技术有限公司 2026-02-27 CN disclosed
US-20250270512-A1 ADDITIVE FOR UNDIFFERENTIATION MAINTAINING MEDIUM AJINOMOTO CO., INC. (JP) 2025-08-28 US disclosed
CN-110494559-B Culture medium additive for non-differentiation maintenance 味之素株式会社 2023-10-31 CN disclosed
US-20200040308-A1 ADDITIVE FOR UNDIFFERENTIATION MAINTAINING MEDIUM AJINOMOTO CO., INC. (JP) 2020-02-06 US disclosed
EP-3604503-A1 ADDITIVE FOR UNDIFFERENTIATION MAINTAINING MEDIUM Ajinomoto Co., Inc. (JP) 2020-02-05 EP disclosed
CN-103694314-B Preparation method of active peptide with snake venom source SHANGHAI INST PHARM INDUSTRY 2015-03-25 CN disclosed